Vancouver, BC — (September 24, 2018) — GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG/ OTC: GBHPF/ FRANKFURT: GHG) announces that the board of Directors has approved, as of September 24, 2018, the issuance of 5,300,000 options to purchase common shares of the Corporation to the current Directors, Officers and Consultants of the Corporation, as per applicable Canadian Securities Exchange, policies all exercisable at a price of $0.16 for a period of five (5) years, subject to the Corporation’s stock option plan and to regulatory approval.
About Global Hemp Group Inc.
Global Hemp Group Inc. (CSE: GHG) (OTC: GBHPF) (FRANKFURT: GHG), is headquartered in Vancouver, British Columbia, Canada, with base operations in Montreal and Los Angeles. The Company is focused on a multi-phased strategy to build a strong presence in the industrial hemp industry in both Canada and the United States. The first phase of this strategy is to develop hemp cultivation with the objective of extracting cannabinoids (CBD, CBG, CBN & CBC) and creating a near term revenue stream that will allow the Company to expand and develop successive phases of the strategy. The second phase of the plan will focus on the development of value-added industrial hemp products utilizing the processing of the whole hemp plant, as envisioned in theCompany’s Hemp Agro-Industrial Zone (HAIZ) strategy.

Forward Looking Statements. Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of Global Hemp Group Inc., including, but not limited to the impact of generaleconomic conditions, industry conditions, volatility of commodity prices, currency fluctuations, dependence upon regulatory approvals, the availability of future financing and exploration risk. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

page1image10050288